HealthDay - WEDNESDAY, April 28 (HealthDay News) -- The Action to Control
Cardiovascular Risk in Diabetes (ACCORD) study was abruptly halted in 2008
when researchers noticed an increase in deaths in the group of type 2
diabetics who were being intensively treated to bring their blood sugar
levels down to near-normal levels.